Disclosure Of Interests In Other Entities [Text Block]

Zealand Pharma - Filing #5889383

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of composition of group [text block]	—	Zealand	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	—	—	—	8,527,704,000 DKK	—	—	—	—	1,779,788,000 DKK	—	—	—	—
Non-current assets	—	—	—	977,896,000 DKK	—	—	—	—	200,205,000 DKK	—	—	—	—
Current liabilities	—	—	—	403,473,000 DKK	—	—	—	—	284,579,000 DKK	—	—	—	—
Non-current liabilities	—	—	—	485,385,000 DKK	—	—	—	—	102,575,000 DKK	—	—	—	—
Revenue	—	62,691,000 DKK	—	—	—	—	—	342,788,000 DKK	—	—	—	—	—
Profit (loss)	- DKK	1,078,828,000 DKK	- DKK	—	- DKK	1,078,828,000 DKK	- DKK	703,739,000 DKK	—	703,739,000 DKK	- DKK	- DKK	—
Comprehensive income	- DKK	1,079,144,000 DKK	- DKK	—	316,000 DKK	1,078,828,000 DKK	- DKK	695,652,000 DKK	—	703,739,000 DKK	- DKK	8,087,000 DKK	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	—	—	480,303,000 DKK	—	—	—	—	449,311,000 DKK	—	—	—	1,069,234,000 DKK
Tax expense (income)	—	4,617,000 DKK	—	—	—	—	—	5,126,000 DKK	—	—	—	—	—